Related references
Note: Only part of the references are listed.Atrial fibrillation and cardiac fibrosis
Christian Sohns et al.
EUROPEAN HEART JOURNAL (2020)
Harnessing the Effects of BTKi on T Cells for Effective Immunotherapy against CLL
Maissa Mhibik et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Amphiregulin promotes cardiac fibrosis post myocardial infarction by inducing the endothelial-mesenchymal transition via the EGFR pathway in endothelial cells
Liang Liu et al.
EXPERIMENTAL CELL RESEARCH (2020)
Flow cytometry in the diagnosis of mature B-cell lymphoproliferative disorders
Camille Debord et al.
INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY (2020)
Novel mouse model resistant to irreversible BTK inhibitors: a tool identifying new therapeutic targets and side effects
H. Yesid Estupinan et al.
BLOOD ADVANCES (2020)
Atrial fibrillation and cardiac fibrosis
Christian Sohns et al.
EUROPEAN HEART JOURNAL (2020)
Precursor B-cell development in bone marrow of Good syndrome patients
Lucia del Pino Molina et al.
CLINICAL IMMUNOLOGY (2019)
BCR-dependent lineage plasticity in mature B cells
Robin Graf et al.
SCIENCE (2019)
EGF (Epidermal Growth Factor) Receptor Ligands in Atrial Fibrillation From Genomic Evidence to the Identification of New Players
Petra Buettner et al.
CIRCULATION-ARRHYTHMIA AND ELECTROPHYSIOLOGY (2019)
Cardiovascular Toxicities Associated With Ibrutinib
Joe-Elie Salem et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2019)
Randomized trial of ibrutinib vs ibrutinib plus rituximab in patients with chronic lymphocytic leukemia
Jan A. Burger et al.
BLOOD (2019)
Data-driven discovery and validation of circulating blood-based biomarkers associated with prevalent atrial fibrillation
Winnie Chua et al.
EUROPEAN HEART JOURNAL (2019)
Ibrutinib-based therapy impaired neutrophils microbicidal activity in patients with chronic lymphocytic leukemia during the early phases of treatment
Alessandro Prezzo et al.
LEUKEMIA RESEARCH (2019)
A genome-wide transcriptomic analysis of protein-coding genes in human blood cells
Mathias Uhlen et al.
SCIENCE (2019)
Ibrutinib modulates the immunosuppressive CLL microenvironment through STAT3-mediated suppression of regulatory B-cell function and inhibition of the PD-1/PD-L1 pathway
K. Kondo et al.
LEUKEMIA (2018)
Circulating Wnt inhibitory factor 1 levels are associated with development of cardiovascular disease
Claudia Ress et al.
ATHEROSCLEROSIS (2018)
iwCLL guidelines for diagnosis, indications for treatment, response assessment, and supportive management of CLL
Michael Hallek et al.
BLOOD (2018)
Hypoxia-inducible factor 2-alpha-dependent induction of amphiregulin dampens myocardial ischemia- reperfusion injury
Michael Koeppen et al.
NATURE COMMUNICATIONS (2018)
Restricted T cell receptor repertoire in CLL-like monoclonal B cell lymphocytosis and early stage CLL
Gonzalo Blanco et al.
ONCOIMMUNOLOGY (2018)
Ibrutinib induces rapid down-regulation of inflammatory markers and altered transcription of chronic lymphocytic leukaemia-related genes in blood and lymph nodes
Marzia Palma et al.
BRITISH JOURNAL OF HAEMATOLOGY (2018)
T cells in chronic lymphocytic leukemia display dysregulated expression of immune checkpoints and activation markers
Marzia Palma et al.
HAEMATOLOGICA (2017)
Restrictions in the T-cell repertoire of chronic lymphocytic leukemia: high-throughput immunoprofiling supports selection by shared antigenic elements
A. Vardi et al.
LEUKEMIA (2017)
T cells in chronic lymphocytic leukemia display dysregulated expression of immune checkpoints and activation markers
Marzia Palma et al.
HAEMATOLOGICA (2017)
Ibrutinib may impair serological responses to influenza vaccination
Abby P. Douglas et al.
HAEMATOLOGICA (2017)
Ibrutinib treatment improves T cell number and function in CLL patients
Meixiao Long et al.
JOURNAL OF CLINICAL INVESTIGATION (2017)
Ibrutinib Therapy Increases T Cell Repertoire Diversity in Patients with Chronic Lymphocytic Leukemia
Qingsong Yin et al.
JOURNAL OF IMMUNOLOGY (2017)
S100A12 in renal and cardiovascular diseases
Alireza Nazari et al.
LIFE SCIENCES (2017)
Identification of TNFSF13, SPATC1L, SLC22A25 and SALL4 as novel susceptibility loci for atrial fibrillation by an exome-wide association study
Yoshiji Yamada et al.
MOLECULAR MEDICINE REPORTS (2017)
Changes in T-cell subpopulations and cytokine network during early period of ibrutinib therapy in chronic lymphocytic leukemia patients: the significant decrease in T regulatory cells number
Monika Podhorecka et al.
ONCOTARGET (2017)
Ibrutinib may impair serological responses to influenza vaccination
Abby P. Douglas et al.
HAEMATOLOGICA (2017)
The cardiac microenvironment uses non-canonical WNT signaling to activate monocytes after myocardial infarction
Ingmar Soeren Meyer et al.
EMBO MOLECULAR MEDICINE (2017)
Enhanced S100A9 and S100A12 expression in acute coronary syndrome
Zafer Buyukterzi et al.
BIOMARKERS IN MEDICINE (2017)
Disruption of in vivo Chronic Lymphocytic Leukemia Tumor-Microenvironment Interactions by Ibrutinib - Findings from an Investigator-Initiated Phase II Study
Carsten U. Niemann et al.
CLINICAL CANCER RESEARCH (2016)
BTK inhibition results in impaired CXCR4 chemokine receptor surface expression, signaling and function in chronic lymphocytic leukemia
S-S Chen et al.
LEUKEMIA (2016)
Stromal cell-derived factor 1α (SDF-1α): A marker of disease burden in patients with atrial fibrillation
Dana Li et al.
SCANDINAVIAN CARDIOVASCULAR JOURNAL (2016)
Ibrutinib efficacy and tolerability in patients with relapsed chronic lymphocytic leukemia following allogeneic HCT
Christine E. Ryan et al.
BLOOD (2016)
Myeloid-Derived Suppressor Cells Express Bruton's Tyrosine Kinase and Can Be Depleted in Tumor-Bearing Hosts by Ibrutinib Treatment
Andrew Stiff et al.
CANCER RESEARCH (2016)
A Tec kinase BTK inhibitor ibrutinib promotes maturation and activation of dendritic cells
Gayathri Natarajan et al.
ONCOIMMUNOLOGY (2016)
Partial reconstitution of humoral immunity and fewer infections in patients with chronic lymphocytic leukemia treated with ibrutinib
Clare Sun et al.
BLOOD (2015)
Treatment with Ibrutinib Inhibits BTK- and VLA-4-Dependent Adhesion of Chronic Lymphocytic Leukemia Cells In Vivo
Sarah E. M. Herman et al.
CLINICAL CANCER RESEARCH (2015)
Targets for Ibrutinib Beyond B Cell Malignancies
A. Berglof et al.
SCANDINAVIAN JOURNAL OF IMMUNOLOGY (2015)
EN-RAGE A Novel Inflammatory Marker for Incident Coronary Heart Disease
Symen Ligthart et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2014)
CLL-cells induce IDOhi CD14+HLA-DRlo myeloid-derived suppressor cells that inhibit T-cell responses and promote TRegs
Regina Jitschin et al.
BLOOD (2014)
Ibrutinib antagonizes rituximab-dependent NK cell-mediated cytotoxicity
Holbrook E. Kohrt et al.
BLOOD (2014)
Molecular Pathways: Targeting the Microenvironment in Chronic Lymphocytic Leukemia-Focus on the B-Cell Receptor
Elisa ten Hacken et al.
CLINICAL CANCER RESEARCH (2014)
Homogenous 96-Plex PEA Immunoassay Exhibiting High Sensitivity, Specificity, and Excellent Scalability
Erika Assarsson et al.
PLOS ONE (2014)
T cells from CLL patients exhibit features of T-cell exhaustion but retain capacity for cytokine production
John C. Riches et al.
BLOOD (2013)
Ibrutinib is an irreversible molecular inhibitor of ITK driving a Th1-selective pressure in T lymphocytes
Jason A. Dubovsky et al.
BLOOD (2013)
WIF1 causes dysfunction of heart in transgenic mice
Dan Lu et al.
TRANSGENIC RESEARCH (2013)
The clinically active BTK inhibitor PCI-32765 targets B-cell receptor- and chemokine-controlled adhesion and migration in chronic lymphocytic leukemia
Martin F. M. de Rooij et al.
BLOOD (2012)
Increased Pro-inflammatory Cytokine Production After Lipopolysaccharide Stimulation in Patients with X-linked Agammaglobulinemia
Maria Edith Gonzalez-Serrano et al.
JOURNAL OF CLINICAL IMMUNOLOGY (2012)
Hypoxia Changes the Expression of the Epidermal Growth Factor (EGF) System in Human Hearts and Cultured Cardiomyocytes
Mathias Munk et al.
PLOS ONE (2012)
The Bruton tyrosine kinase inhibitor PCI-32765 blocks B-cell activation and is efficacious in models of autoimmune disease and B-cell malignancy
Lee A. Honigberg et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Increased express on of stem cell factor and its receptor after left ventricular assist device support: A potential novel target for therapeutic interventions in heart failure
Jama Jahanyar et al.
JOURNAL OF HEART AND LUNG TRANSPLANTATION (2008)
Stem cell-related cardiac gene expression early after murine myocardial infarction
Susanne Vandervelde et al.
CARDIOVASCULAR RESEARCH (2007)
Discovery of selective irreversible inhibitors for Bruton's tyrosine kinase
Zhengying Pan et al.
CHEMMEDCHEM (2007)
Bruton's tyrosine kinase and phospholipase C gamma 2 mediate chemokine-controlled B cell migration and homing
David J. J. de Gorter et al.
IMMUNITY (2007)
Roles for phosphoinositide 3-kinases, Bruton's tyrosine kinase, and Jun kinases in B lymphocyte chemotaxis and homing
Saida Ortolano et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2006)
Reduced frequencies and suppressive function of CD4+CD25hi regulatory T cells in patients with chronic lymphocytic leukemia after therapy with fludarabine
M Beyer et al.
BLOOD (2005)
Tissue-specific muscle, neural and liver stem/progenitor cells reside in the bone marrow, respond to an SDF-1 gradient and are mobilized into peripheral blood during stress and tissue injury
M Kucia et al.
BLOOD CELLS MOLECULES AND DISEASES (2004)
Bruton's tyrosine kinase defect in dendritic cells from X-linked agammaglobulinaemia patients does not influence their differentiation, maturation and antigen-presenting cell function
MC Gagliardi et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2003)
T type 1/type 2 subsets balance in B-cell chronic lymphocytic leukemia - the three-color flow cytometry analysis
M Podhorecka et al.
LEUKEMIA RESEARCH (2002)
Human chronic lymphocytic leukemia modeled in mouse by targeted TCL1 expression
R Bichi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Composition of precursor B-cell compartment in bone marrow from patients with X-linked agammaglobulinemia compared with healthy children
JG Noordzij et al.
PEDIATRIC RESEARCH (2002)
Share Paper
